All Times EDT
Legend: CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
Activity Details
481
Wed, 8/10/2022,
2:00 PM -
3:50 PM
CC-140B
Dose Finding, Dose Selection, and Early-Phase Trials — Contributed Papers
Biopharmaceutical Section
Chair(s): Na Hu, BI
2:05 PM
A Comparative Study of in Vitro Dose-Response Estimation Under Extreme Observations
Xinying Fang, Pennsylvania State University ; Shouhao Zhou, Pennsylvania State University
2:20 PM
Machine Learning in Pharmacogenomics
Jessica Kim, U.S. Food and Drug Administration ; Stella Grosser, U.S. Food and Drug Administration
2:35 PM
Early Completion of Model-Assisted Designs for Dose-Finding Trials
Masahiro Kojima, Kyowa Kirin Co, Ltd.
2:50 PM
A Non-Parametric Bayesian Approach for Monotonic Dose-Response Model
Nairita Ghosal, Merck & Co., Inc.
3:05 PM
Comparison of Dose Limiting Toxicity Rates for Bayesian Dose Escalation Designs
Richard John McNally, Labcorp
3:20 PM
Justifying a Sample Size in Phase 2 Dose Selection Study Using a Bayesian Meta-Analytic-Predictive Approach with a Robust Prior Component
Mehreteab Aregay, Daiichi Sankyo Inc
3:35 PM
Floor Discussion
